+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Mesalazine Suppositories Market - Global Forecast 2025-2030- Product Image
Mesalazine Suppositories Market - Global Forecast 2025-2030- Product Image
Sale

Mesalazine Suppositories Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6145395
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Mesalazine suppositories represent an intersection of advanced drug delivery, regulatory shifts, and evolving patient expectations. Market growth is underpinned by innovation in formulation technologies, the integration of digital health strategies, and adaptive approaches to supply chain resilience—making it critical for senior decision-makers to anticipate changing dynamics and seize emerging opportunities.

Market Snapshot: Mesalazine Suppositories

The global mesalazine suppository market is experiencing robust expansion, shaped by regulatory harmonization, accelerating innovation in targeted drug delivery, and higher patient demand for convenient, effective treatments. Notable trends include the adoption of advanced release matrices, expanded supply chain networks, and increased use of digital patient adherence solutions. Growth trajectories vary regionally, driven by the structure of local healthcare systems, reimbursement frameworks, and infrastructure development.

Scope & Segmentation of the Mesalazine Suppository Market

  • Product Types: Branded formulations, leveraging proprietary excipient technologies and strong clinical endorsements; Generic offerings, competing on price and accessibility.
  • Distribution Channels: Hospital pharmacies, supporting both inpatient and outpatient care; Online pharmacies, enabling convenience and discreet delivery; Retail pharmacies, balancing accessibility with pharmacist-led support.
  • End Users: Clinics, with a focus on acute management; Home care services, prioritizing simplified regimens; Hospitals, integrating products within comprehensive treatment pathways.
  • Dosage Strengths: 500 mg options, preferred for mild presentations; 1000 mg variants, addressing moderate to severe cases with optimized release kinetics.
  • Patient Age Groups: Adult patients seeking ease of administration; Pediatric populations requiring palatable, clearly instructed formulations.
  • Regions Covered: Americas, including key U.S. states (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, and Argentina; Europe, Middle East & Africa, covering the United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland; Asia-Pacific, comprising China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan.
  • Key Companies: Takeda Pharmaceutical Company Limited, Ferring International Center S.A., Dr. Falk Pharma GmbH, Recordati Rare Diseases S.r.l., Teva Pharmaceuticals Europe B.V., Sandoz International GmbH, Viatris Holding Inc., Lupin Limited, Intas Pharmaceuticals Limited, Cipla Limited.

Key Takeaways for Senior Decision-Makers

  • Formulation advancements are setting new standards for drug delivery and patient adherence, with branded products maintaining a premium profile through exclusive technologies.
  • Digital health integration, including automated reminders and telehealth modules, is enhancing patient outcomes and professional oversight.
  • Segmentation reveals distinct growth avenues: pediatric-friendly innovations and self-administration support are key in select regions, while extended-release formulations are favored in developed markets.
  • Partnerships between manufacturers, local API producers, and digital health startups are accelerating pipeline development and de-risking supply chains.
  • Companies optimizing operational excellence—such as streamlining batch production and developing teleconsultation support—are gaining an edge in cost-sensitive regions.
  • Data-driven decision-making, from preclinical screening to post-launch pharmacovigilance, is improving time-to-market and regulatory compliance.

Tariff Impact on Supply Chain and Cost Management

Updated 2025 U.S. tariff policies have increased duties on imported active pharmaceutical ingredients (APIs), prompting manufacturers to diversify supply sources and consider vertical integration. This has led to local and regional partnerships, enhancing resilience against trade-related disruptions while reshaping procurement and distribution models to prioritize transparency and domestic sourcing.

Primary Keyword: Mesalazine Suppositories in Market Analysis

Mesalazine suppositories occupy a distinctive niche within the pharmaceutical landscape. Their positioning reflects the convergence of regulatory updates, evolving technology platforms, and market-specific patient preferences, each influencing strategic investment decisions and shaping future innovation.

Methodology & Data Sources

This report applies a rigorous research framework: primary data was collected via expert interviews with clinicians, formulation scientists, and healthcare procurement leaders, validated with surveys from senior pharmaceutical executives. Secondary data compilation involved peer-reviewed publications, regulatory guidelines, industry reports, patent records, and comprehensive conference proceedings. Triangulation methods ensured consistency and reliability of findings.

Why This Report Matters

  • Actionable guidance allows stakeholders to adapt product portfolios to evolving clinical, economic, and regulatory trends—reducing commercial and operational risk.
  • Segmentation and regional analyses identify unique growth opportunities and help shape localized engagement strategies for improved market access and patient outcomes.
  • Insight into industry-leading innovation, policy shifts, and digital integration offers a forward-looking roadmap for next-generation product and supply chain development.

Conclusion

The mesalazine suppository market is rapidly evolving, shaped by a complex interplay of innovation, policy changes, and differentiated regional demand. Companies that align their strategies with these trends are well-positioned for ongoing market success.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising pediatric ulcerative colitis diagnoses driving demand for age appropriate mesalazine suppositories formulation
5.2. Development of bioadhesive polymer matrices to improve mesalazine suppository retention and localized drug release
5.3. Expansion of generic mesalazine suppository approvals leading to intensified price competition and market fragmentation
5.4. Regulatory fast track approvals in emerging markets boosting accessibility of low cost mesalazine suppositories for ulcerative colitis patients
5.5. Integration of digital health platforms and remote patient monitoring to improve adherence to mesalazine suppository regimens
5.6. Advances in microencapsulation and sustained release technologies enhancing targeted colonic delivery of mesalazine suppositories
5.7. Growing utilization of combination therapies pairing mesalazine suppositories with biologics for refractory ulcerative colitis management
5.8. Patient centric packaging innovations for mesalazine suppositories improving ease of administration and treatment compliance
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Mesalazine Suppositories Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Mesalazine Suppositories Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacy
9.3. Online Pharmacy
9.4. Retail Pharmacy
10. Mesalazine Suppositories Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Home Care
10.4. Hospitals
11. Mesalazine Suppositories Market, by Dosage Strength
11.1. Introduction
11.2. 1000 Mg
11.3. 500 Mg
12. Mesalazine Suppositories Market, by Patient Age Group
12.1. Introduction
12.2. Adult
12.3. Pediatric
13. Americas Mesalazine Suppositories Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Mesalazine Suppositories Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Mesalazine Suppositories Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Takeda Pharmaceutical Company Limited
16.3.2. Ferring International Center S.A.
16.3.3. Dr. Falk Pharma GmbH
16.3.4. Recordati Rare Diseases S.r.l.
16.3.5. Teva Pharmaceuticals Europe B.V.
16.3.6. Sandoz International GmbH
16.3.7. Viatris Holding Inc.
16.3.8. Lupin Limited
16.3.9. Intas Pharmaceuticals Limited
16.3.10. Cipla Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. MESALAZINE SUPPOSITORIES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MESALAZINE SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS MESALAZINE SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC MESALAZINE SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC MESALAZINE SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. MESALAZINE SUPPOSITORIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. MESALAZINE SUPPOSITORIES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. MESALAZINE SUPPOSITORIES MARKET: RESEARCHAI
FIGURE 26. MESALAZINE SUPPOSITORIES MARKET: RESEARCHSTATISTICS
FIGURE 27. MESALAZINE SUPPOSITORIES MARKET: RESEARCHCONTACTS
FIGURE 28. MESALAZINE SUPPOSITORIES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MESALAZINE SUPPOSITORIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY 1000 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY 1000 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY 500 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY 500 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS MESALAZINE SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS MESALAZINE SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 67. CANADA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 68. CANADA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 69. CANADA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. CANADA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. CANADA MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. CANADA MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. CANADA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 74. CANADA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 75. CANADA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 76. CANADA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 77. MEXICO MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 78. MEXICO MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 79. MEXICO MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. MEXICO MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. MEXICO MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. MEXICO MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. MEXICO MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 84. MEXICO MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 85. MEXICO MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 86. MEXICO MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 87. BRAZIL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 88. BRAZIL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 97. ARGENTINA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 98. ARGENTINA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED KINGDOM MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. UNITED KINGDOM MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 129. GERMANY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. GERMANY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. GERMANY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. GERMANY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. GERMANY MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. GERMANY MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. GERMANY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 136. GERMANY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 137. GERMANY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 138. GERMANY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 139. FRANCE MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. FRANCE MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. FRANCE MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. FRANCE MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. FRANCE MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. FRANCE MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. FRANCE MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 146. FRANCE MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 147. FRANCE MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 148. FRANCE MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 149. RUSSIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. RUSSIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. RUSSIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 152. RUSSIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 159. ITALY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. ITALY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. ITALY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. ITALY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. ITALY MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. ITALY MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. ITALY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 166. ITALY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 167. ITALY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 168. ITALY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 169. SPAIN MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 170. SPAIN MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 171. SPAIN MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. SPAIN MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. SPAIN MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. SPAIN MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. SPAIN MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 176. SPAIN MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 177. SPAIN MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 178. SPAIN MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 190. SAUDI ARABIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. SAUDI ARABIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. SOUTH AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. SOUTH AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 209. DENMARK MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. DENMARK MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. DENMARK MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. DENMARK MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. DENMARK MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. DENMARK MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. DENMARK MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 216. DENMARK MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 217. DENMARK MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 218. DENMARK MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 219. NETHERLANDS MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. NETHERLANDS MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. NETHERLANDS MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. NETHERLANDS MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 229. QATAR MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 230. QATAR MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 231. QATAR MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. QATAR MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. QATAR MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. QATAR MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. QATAR MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 236. QATAR MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 237. QATAR MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 238. QATAR MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 239. FINLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. FINLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. FINLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. FINLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. FINLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. FINLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. FINLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 246. FINLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 247. FINLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 248. FINLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 249. SWEDEN MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. SWEDEN MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. SWEDEN MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 252. SWEDEN MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 259. NIGERIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. NIGERIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. NIGERIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. NIGERIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 269. EGYPT MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. EGYPT MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. EGYPT MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. EGYPT MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. EGYPT MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. EGYPT MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. EGYPT MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 276. EGYPT MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 277. EGYPT MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. EGYPT MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. TURKEY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. TURKEY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. TURKEY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. TURKEY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. TURKEY MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. TURKEY MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. TURKEY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 286. TURKEY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 287. TURKEY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 288. TURKEY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 289. ISRAEL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. ISRAEL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. ISRAEL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 292. ISRAEL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 293. ISRAEL MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. ISRAEL MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 299. NORWAY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. NORWAY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. NORWAY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. NORWAY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. NORWAY MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. NORWAY MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. NORWAY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 306. NORWAY MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 307. NORWAY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 308. NORWAY MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 309. POLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. POLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. POLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. POLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. POLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. POLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. POLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2018-2024 (USD MILLION)
TABLE 316. POLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY DOSAGE STRENGTH, 2025-2030 (USD MILLION)
TABLE 317. POLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 318. POLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 319. SWITZERLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. SWITZERLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. SWITZERLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 322. SWITZERLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 323. SWITZERLAND MESALAZINE SUPPOSITORIES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Mesalazine Suppositories market report include:
  • Takeda Pharmaceutical Company Limited
  • Ferring International Center S.A.
  • Dr. Falk Pharma GmbH
  • Recordati Rare Diseases S.r.l.
  • Teva Pharmaceuticals Europe B.V.
  • Sandoz International GmbH
  • Viatris Holding Inc.
  • Lupin Limited
  • Intas Pharmaceuticals Limited
  • Cipla Limited

Related Topics

Related Reports

Mesalazine Market - Global Forecast 2025-2030 - Product Image

Mesalazine Market - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Mesalazine API Market - Global Forecast 2025-2030 - Product Image

Mesalazine API Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
N-Propionyl Mesalazine-D5 (CAS 1189861-06-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

N-Propionyl Mesalazine-D5 (CAS 1189861-06-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Mesalamine (CAS 89-57-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Mesalamine (CAS 89-57-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Laxatives Global Market Report 2025 - Product Image

Laxatives Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.